We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$550M
AUM Growth
-$3.13M
Cap. Flow
+$793K
Cap. Flow %
0.14%
Top 10 Hldgs %
27.76%
Holding
1,111
New
57
Increased
238
Reduced
302
Closed
74

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$1.08M
2
BF.B icon
Brown-Forman Class B
BF.B
+$522K
3
HD icon
Home Depot
HD
+$474K
4
AES icon
AES
AES
+$444K
5
KHC icon
Kraft Heinz
KHC
+$427K

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 13.84%
3 Industrials 11.4%
4 Real Estate 9.08%
5 Consumer Discretionary 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXH icon
351
First Trust Health Care AlphaDEX Fund
FXH
$1.12B
$91.9K 0.02%
807
+1
+0.1% +$113
EW icon
352
Edwards Lifesciences
EW
$53B
$91.7K 0.02%
1,076
ACMR icon
353
ACM Research
ACMR
$5.53B
$91.2K 0.02%
2,313
MGK icon
354
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.8B
$90.8K 0.02%
1,100
VBK icon
355
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$90.6K 0.02%
300
-9
-3% -$2.71K
RJF icon
356
Raymond James Financial
RJF
$34.5B
$90.6K 0.02%
+564
New +$91.1K
TTE icon
357
TotalEnergies
TTE
$195B
$88.7K 0.02%
1,351
BBIO icon
358
BridgeBio Pharma
BBIO
$16.6B
$88.3K 0.02%
1,155
+612
+113% +$40.2K
GD icon
359
General Dynamics
GD
$107B
$88.1K 0.02%
262
+1
+0.4% +$341
ARQT icon
360
Arcutis Biotherapeutics
ARQT
$3.26B
$87.5K 0.02%
3,012
+1,606
+114% +$41.1K
GS icon
361
Goldman Sachs
GS
$301B
$87.3K 0.02%
99
+1
+1% +$816
CME icon
362
CME Group
CME
$94.8B
$86.7K 0.02%
317
+176
+125% +$47.8K
PNC icon
363
PNC Financial Services
PNC
$100B
$86.6K 0.02%
415
BTI icon
364
British American Tobacco
BTI
$123B
$86.3K 0.02%
1,524
NGG icon
365
National Grid
NGG
$79.9B
$85.4K 0.02%
1,104
-16
-1% -$1.2K
APLD icon
366
Applied Digital
APLD
$8.37B
$85.2K 0.02%
3,476
+726
+26% +$20.9K
CR icon
367
Crane Co
CR
$12.7B
$84.7K 0.02%
459
BA icon
368
Boeing
BA
$184B
$84.5K 0.02%
389
-106
-21% -$21.8K
NVO
369
Novo Nordisk
NVO
$209B
$83.4K 0.02%
1,639
-200
-11% -$10.2K
CRUS icon
370
Cirrus Logic
CRUS
$6.11B
$83K 0.02%
700
-30
-4% -$3.69K
TFC icon
371
Truist Financial
TFC
$63.4B
$82.3K 0.02%
1,672
REGN icon
372
Regeneron Pharmaceuticals
REGN
$83.2B
$81K 0.01%
105
+53
+102% +$36K
GSK icon
373
GSK
GSK
$104B
$80.9K 0.01%
1,650
VDC icon
374
Vanguard Consumer Staples ETF
VDC
$7.94B
$80.3K 0.01%
380
ROIV icon
375
Roivant Sciences
ROIV
$25.8B
$79.9K 0.01%
3,680
+1,925
+110% +$38K

Similar funds

Truvestments Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Truvestments Capital held 1,111 positions worth $550M, down 0.56% from $553M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Truvestments Capital's Q4 2025 filing shows 57 new, 238 increased, 302 reduced and 74 closed positions. Its largest new stake was BitMine Immersion Technologies: 17,515 shares worth $476K. The largest sale was Invesco QQQ Trust, an estimated $1.08M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.

  • Truvestments Capital's largest Q4 2025 buy was BitMine Immersion Technologies: 17,515 shares worth $476K.
  • Truvestments Capital added most to iShares Bitcoin Trust in Q4 2025, an estimated $1.11M increase.
  • Truvestments Capital's biggest Q4 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.08M.
  • Truvestments Capital fully exited Colgate-Palmolive in Q4 2025, selling an estimated $398K.
  • Truvestments Capital's ten largest holdings make up 28% of its $550M portfolio in Q4 2025.
  • Truvestments Capital opened 57 new positions and closed 74 in Q4 2025.
  • Truvestments Capital's portfolio value fell 0.56% quarter-over-quarter to $550M.

Based on Truvestments Capital's 13F filing for Q4 2025, filed 13 Feb 2026.